 The study evaluated the clinical utility of microRNAs 19a3p and 99a5p as potential diagnostic markers for non-invasive bladder cancer, finding reduced expression in most cases and ability to differentiate between low and high-grade disease in non-invasive stages. This article was authored by Edita Mborkowska, Peter Cutwin, Dorida Raleca, and others.